Evoq Remedies Stock Screener | Share Price & Fundamental Analysis
Track Evoq Remedies share price live with TickJournal's free stock screener.
Analyze Evoq Remedies share price history trends and compare 52-week high low
levels.
Calculate EVOQ stock fair value using fundamental analysis and view live share price charts.
Determine Evoq Remedies share intrinsic value and compare it with current EVOQ share price.
Record your Evoq Remedies trades in TickJournal's free trading journal and track your portfolio performance.
Evoq Remedies Market Cap
₹9.03 Cr.
EPS (TTM)
₹0.04
Dividend Yield
-
Debt to Equity
0.06
Evoq Remedies 52 Week Low
-
Operating Margin
-
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹50.00
Total Equity
₹45.00
Evoq Remedies Share Price History - Stock Screener Chart
Screen EVOQ historical share price movements with interactive charts. Analyze price trends and patterns.
Evoq Remedies Company Profile - Fundamental Screener
Screen Evoq Remedies company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for EVOQ shares.
Sector
Commercial Services
Industry
Trading & Distributors
Sub-Sector
Trading & Distributors
Segment
E
ISIN
INE0JVD01011
Evoq Remedies Balance Sheet Screener
Screen EVOQ balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 50 | 37 | 35 | 33 | 8 | 6 | 2 |
| Current Assets | 50 | 37 | 35 | 33 | 8 | 6 | 2 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | |||||||
| Total Liabilities | 50 | 37 | 35 | 33 | 8 | 6 | 2 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 45 | 25 | 25 | 23 | 1 | 0 | 0 |
| Share Capital | 25 | 14 | 14 | 14 | 0 | 0 | 0 |
| Reserves & Surplus | 20 | 12 | 11 | 10 | 1 | 0 | 0 |
Evoq Remedies Income Statement Screener - Profit & Revenue Analysis
Screen Evoq Remedies income statement and profit fundamentals.
Analyze EVOQ quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Evoq Remedies share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 14 | 6 | 26 | 17 | 10 | 9 | 3 |
| Expenses | 0 | 14 | 6 | 24 | 15 | 9 | 9 | 3 |
| EBITDA | 0 | 0 | 1 | 2 | 2 | 1 | 0 | 0 |
| Operating Profit % | 0.00% | -19.00% | -40.00% | -18.00% | 9.00% | 10.00% | 0.00% | 1.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 1 | 2 | 2 | 1 | 0 | 0 |
| Tax | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 1 | 2 | 1 | 1 | 0 | 0 |
| EPS | 0.00 | 0.04 | 0.33 | 1.19 | 0.70 | 715.00 | 0.00 | 0.16 |
Evoq Remedies Cash Flow Screener - Liquidity Fundamentals
Screen EVOQ cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | -15 | 5 | -4 | -26 | 0 | 0 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | 15 | -5 | 1 | 30 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | -3 | 3 | 0 | 0 | 0 |
Evoq Remedies Shareholding Pattern Screener
See Evoq Remedies shareholding pattern with promoter, FII, and DII holdings.
Check Evoq Remedies promoter holding and ownership changes for EVOQ on TickJournal.
| Item | 2025-Mar | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2023-Mar | 2023-Sept | 2022-Feb |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 11.21% | 11.21% | 20.53% | 11.21% | 11.21% | 73.53% | 73.53% | 100.00% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 84.74% | 83.89% | 73.38% | 85.57% | 85.75% | 25.21% | 24.91% | 0.00% |
| Other Holding | 4.05% | 4.90% | 6.09% | 3.21% | 3.04% | 1.26% | 1.56% | 0.00% |
| Shareholder Count | 1,723 | 1,679 | 1,672 | 1,588 | 1,577 | 707 | 727 | 7 |
Evoq Remedies Share Dividend Screener - Share Yield Analysis
Check Evoq Remedies dividend history with payout and yield data.
View Evoq Remedies dividend details including ex-dates and amounts for EVOQ stock.
Evoq Remedies Stock Index Membership
See which indices include Evoq Remedies stock.
Check EVOQ index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Evoq Remedies Market Events Screener - Corporate Actions
Get Evoq Remedies corporate actions including splits, bonuses, and buybacks.
Check Evoq Remedies stock events that may affect EVOQ share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -3.40% | ||
| Annual General Meeting | NA | 7.43% | ||
| 2025-10-10 | 2025-10-10 | Quarterly Result Announcement | NA | 14.87% |
| 2025-06-03 | 2025-06-03 | Extraordinary General Meeting | NA | 22.05% |
| 2025-04-10 | 2025-04-10 | Quarterly Result Announcement | NA | 9.77% |
| 2025-03-03 | 2025-03-03 | Quarterly Result Announcement | NA | 0.00% |
| 2024-02-28 | 2024-02-28 | Extraordinary General Meeting | NA | -1.84% |
| 2021-07-28 | 2021-07-28 | Change Of Name | NA | - |
Evoq Remedies Competitors Screener - Peer Comparison
Screen EVOQ competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Redington | 21,471 | 11.30 | 99,562 | 11.11% | 1,821 | 47.44 |
| Elitecon International | 17,309 | 66.97 | 551 | 55040.00% | 70 | 46.63 |
| MMTC | 8,630 | 39.01 | 263 | 28.63% | 87 | 47.12 |
| BN Agrochem | 3,722 | 57.00 | 367 | 5071.83% | 20 | 51.53 |
| MSTC | 3,455 | 8.30 | 388 | -25.38% | 407 | 52.78 |
| Ravindra Energy | 3,006 | 43.02 | 262 | 79.10% | 23 | 59.24 |
| TCC Concept | 2,174 | 44.24 | 90 | 14.72% | 42 | 47.76 |
| Vintage Coffee & Beverages | 2,038 | 38.32 | 313 | 136.92% | 40 | 44.38 |
| Creative Newtech | 1,127 | 18.43 | 1,802 | 3.48% | 53 | 59.67 |
| Polo Queen Industrial And Fintech | 1,081 | 411.50 | 81 | 15.16% | 3 | 41.41 |
Evoq Remedies Company Announcements - News Screener
Screen EVOQ latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-10-24 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-10-23 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-10-23 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-10-10 | Integrated Filling (Finance) | View |
| 2025-10-10 | Financial Result For Half Year Ended On 30Th September 2025 | View |
| 2025-10-10 | Board Meeting Outcome for Outcome Of Board Meeting | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-09 | Board Meeting Intimation for Intimation Of Rescheduling Of Board Meeting | View |
| 2025-10-03 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 9Th October 2025 | View |
| 2025-09-30 | Closure of Trading Window | View |
| 2025-09-19 | Voting Results Of The Annual General Meeting | View |
| 2025-09-19 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-17 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-08-26 | Intimation Regarding Book Closure | View |
| 2025-08-26 | Reg. 34 (1) Annual Report. | View |
| 2025-08-26 | Intimation Of The Annual General Meeting To Be Held On 17Th September 2025 | View |
| 2025-08-26 | Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s | View |
| 2025-08-26 | Board Meeting Outcome for Outcome Of Board Meeting And Intimation As Per Regulation 30 Of SEBI (LODR) Regulation 2015 | View |
| 2025-08-21 | Intimation For Withdraw The Proposals For Preferential Issue Of Equity Shares Which Were Earlier Approved By The Board At Its Meeting Held On 29Th April 2025. | View |
| 2025-08-21 | Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Thursday 21St August 2025 | View |